Position in EWTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,666,126
+$1,034,616 QoQ
Shares Held
90,232
+8.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 223 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. EWTX ranks #67 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in EWTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,666,126 | 90,232 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,631,510 | 83,540 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,111,136 | 85,075 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,700,326 | 104,829 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,474,652 | 112,483 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,394,414 | 108,837 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $2,733,999 | 102,397 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,692,273 | 100,872 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,769,824 | 98,269 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,536,318 | 84,228 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $703,803 | 64,333 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $364,485 | 63,610 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $490,420 | 63,280 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $389,067 | 58,331 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $455,850 | 50,990 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $434,386 | 44,145 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $332,043 | 41,714 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $357,551 | 36,861 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $466,208 | 30,511 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||